Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Here's How Much $1000 Invested In T-Mobile US 5 Years Ago Would Be Worth Today

T-Mobile US (NASDAQ:TMUS) has outperformed the market over the past 5 years by 2.74% on an annualized basis producing an average annual return of 15.11%. Currently, T-Mobile US has a market capitalization of $165.94 billion.

Benzinga

Recap: Bandwidth Q1 Earnings

Bandwidth (NASDAQ:BAND) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Bandwidth beat estimated earnings by 212.5%, reporting an EPS of $0.09 versus an estimate of $-0.08.

Benzinga

Recap: Diodes Q1 Earnings

Diodes (NASDAQ:DIOD) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Diodes beat estimated earnings by 12.18%, reporting an EPS of $1.75 versus an estimate of $1.56.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30

Benzinga

Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 4, 2022

GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 15.71% at $3.24

Benzinga

Barrett Bus Servs: Q1 Earnings Insights

Barrett Bus Servs (NASDAQ:BBSI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:05 PM. Here's what investors need to know about the announcement.

Benzinga

Fortinet: Q1 Earnings Insights

Fortinet (NASDAQ:FTNT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Fortinet beat estimated earnings by 18.99%, reporting an EPS of $0.94 versus an estimate of $0.79.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap: Tandem Diabetes Care Q1 Earnings

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

10x Genomics: Q1 Earnings Insights

10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings 10x Genomics missed estimated earnings by 22.58%, reporting an EPS of $-0.38 versus an estimate of $-0.31.

Benzinga

Mirati Therapeutics: Q1 Earnings Insights

Mirati Therapeutics (NASDAQ:MRTX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Benzinga

Etsy: Q1 Earnings Insights

Etsy (NASDAQ:ETSY) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Etsy beat estimated earnings by 1.69%, reporting an EPS of $0.6 versus an estimate of $0.59.

Benzinga

Ultragenyx Pharmaceutical's Earnings Outlook

Ultragenyx Pharmaceutical (NASDAQ:RARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Ultragenyx Pharmaceutical will report an earnings per share (EPS) of $-1.76.

Benzinga

Expert Ratings for Infinera

Analysts have provided the following ratings for Infinera (NASDAQ:INFN) within the last quarter:

Benzinga

Preview: Relay Therapeutics's Earnings

Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Relay Therapeutics will report an earnings per share (EPS) of $-0.62.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Oncternal Therapeutics's Earnings Outlook

Oncternal Therapeutics (NASDAQ:ONCT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oncternal Therapeutics will report an earnings per share (EPS) of $-0.20.

Benzinga

Gritstone Bio's Earnings Outlook

Gritstone Bio (NASDAQ:GRTS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Gritstone Bio will report an earnings per share (EPS) of $-0.37.

Benzinga

19 Analysts Have This to Say About Lyft

Analysts have provided the following ratings for Lyft (NASDAQ:LYFT) within the last quarter:

Benzinga

Earnings Outlook For Apollo Medical Holdings

Apollo Medical Holdings (NASDAQ:AMEH) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Apollo Medical Holdings will report an earnings per share (EPS) of $0.32.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's How Much You Would Have Made Owning NXP Semiconductors Stock In The Last 10 Years

NXP Semiconductors (NASDAQ:NXPI) has outperformed the market over the past 10 years by 10.49% on an annualized basis producing an average annual return of 22.61%. Currently, NXP Semiconductors has a market capitalization of $48.59 billion.

Benzinga

Earnings Outlook For Eagle Bulk Shipping

Eagle Bulk Shipping (NASDAQ:EGLE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Eagle Bulk Shipping will report an earnings per share (EPS) of $4.67.

Benzinga

Relmada Therapeutics Earnings Preview

Relmada Therapeutics (NASDAQ:RLMD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Relmada Therapeutics will report an earnings per share (EPS) of $-1.27.

Benzinga

Earnings Outlook For Vir Biotechnology

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vir Biotechnology will report an earnings per share (EPS) of $3.78.

Benzinga

5 Analysts Have This to Say About eHealth

Within the last quarter, eHealth (NASDAQ:EHTH) has observed the following analyst ratings:

Benzinga

Looking Into Charter Communications's Recent Short Interest

Charter Communications's (NASDAQ:CHTR) short percent of float has fallen 25.66% since its last report. The company recently reported that it has 7.43 million shares sold short, which is 5.59% of all regular shares that are available for trading.

Benzinga

If You Invested $100 In Fortinet 10 Years Ago, Here's How Much You Would Have Today

Fortinet (NASDAQ:FTNT) has outperformed the market over the past 10 years by 15.61% on an annualized basis producing an average annual return of 27.65%. Currently, Fortinet has a market capitalization of $45.88 billion.

1 … 630 631 632 633

Organisations

Charter Communications

Ultragenyx Pharmaceutical

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.